Dr. Deepak Kilari
Claim this profileMedical College of Wisconsin
Studies Cancer
Studies Prostate Cancer
11 reported clinical trials
26 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
ALK positive
2Prostate Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Deepak Kilari is currently running
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Cabozantinib + Atezolizumab
for Bladder Cancer
This is an open-label phase II study assessing the activity of cabozantinib combined with atezolizumab in patients with resectable muscle-invasive urothelial carcinoma who are ineligible for cisplatin-based therapy or decline cisplatin-based therapy. Each cycle equals 21 days. The dose of atezolizumab is 1200 mg IV flat dose every 3 weeks (Day 1) plus cabozantinib 40 mg orally daily (Day 1 through Day 21). Patients will receive three cycles of treatment prior to cystectomy unless they discontinue treatment for unacceptable toxicity or progressive disease by RECIST v1.1 or withdraw consent.
Recruiting1 award Phase 220 criteria
More about Deepak Kilari
Clinical Trial Related4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Deepak Kilari has experience with
- Cabozantinib
- CCW702
- Atezolizumab
- Cystectomy
- Anti-PD-(L)1 Antibody Therapy
- SRK-181
Breakdown of trials Deepak Kilari has run
Cancer
Prostate Cancer
Renal Cell Carcinoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deepak Kilari specialize in?
Deepak Kilari focuses on Cancer and Prostate Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Deepak Kilari currently recruiting for clinical trials?
Yes, Deepak Kilari is currently recruiting for 2 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Deepak Kilari has studied deeply?
Yes, Deepak Kilari has studied treatments such as Cabozantinib, CCW702, Atezolizumab.
What is the best way to schedule an appointment with Deepak Kilari?
Apply for one of the trials that Deepak Kilari is conducting.
What is the office address of Deepak Kilari?
The office of Deepak Kilari is located at: Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Medical College of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.